99%+ Purity Guarantee

Undergoes independent third-party verification before release. Tested to confirm ≥99% purity.

Buy GHRP-6 (10mg) Online

Name: GHRP-6 (10mg)
Brand: NOVERA COMPOUNDS
Availability: InStock

Coming Soon

GHRP-6 is a synthetic peptide studied for its role in growth hormone release and appetite-related signaling. Research suggests that it may influence endocrine and metabolic regulation, primarily through stimulation of ghrelin receptors involved in hormone secretion and feeding behavior.

General info

Brand	NOVERA COMPOUNDS
Strength	10mg
CAS	87616-84-0
Chemical Formula	C₄₆H₅₆N₁₂O₆
Molecular weight	873.03 g/mol
Peptide Sequence	His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
Synonyms	GHRP6, Growth Hormone Releasing Peptide-6
Storage	Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.

Disclaimer: Sold as a research-grade lyophilized peptide in dry powder form. Requires reconstitution under controlled laboratory conditions. Reconstitution agents are not included.

For Research Use Only (RUO): Not for human or animal use, consumption, injection, or application. Not for diagnostic, therapeutic, or clinical purposes.

Buy More Peptides for Research Buy More Muscle Growth & Performance Peptides Products

Free Shipping Over $1000

With fast order dispatch

Guaranteed Product Authenticity

All products contain original LOT numbers

Secure SSL
Encryption

Your data is safe with us

No Order
Minimum

Get the exact quantity you need.

Why Novera Compounds?

Precision-Synthesized Peptides

Advanced synthesis techniques ensure high structural fidelity and ≥99% purity.

Third-Party Verified Quality:

Independent laboratories confirm identity, purity, and batch consistency.

Research-Grade Reliability:

Designed for reproducible laboratory and analytical applications.

Strict Regulatory Compliance:

Products meet Research Use Only (RUO) standards and relevant laboratory regulations.

Documented Transparency:

Certificates of Analysis and quality verification reports provided for every lot.

555a76c773c8ed79615174887299fb4c5c66d2ad

GHRP-6 (10mg) About This Product

GHRP-6 is a synthetic growth hormone–releasing hexapeptide with a molecular weight of approximately 840 Da. The GHRP-6 peptide incorporates both L- and D-amino acid residues, a structural feature that reduces proteolytic susceptibility and alters receptor-interaction profiles, enhancing stability and utility in experimental environments.

GHRP-6 has been examined in laboratory and preclinical research settings for its role as a synthetic agonist of the growth hormone secretagogue receptor 1a (GHS-R1a), also known as the ghrelin receptor. Activation of GHS-R1a initiates Gq/phospholipase C (PLC) signaling and calcium-dependent intracellular cascades that regulate growth hormone release and hypothalamic–pituitary axis feedback under controlled experimental conditions.

This product is supplied as a sterile, lyophilized powder with a reported purity ≥98%, packaged in a sealed, research-grade vial. Laboratories that buy GHRP-6 peptide commonly use this format for non-clinical investigations involving endocrine signaling, metabolic regulation, and receptor-mediated pathway analysis.

GHRP-6 (10mg) Key Features and Benefits

GHRP-6 (10mg) is formatted to support consistent handling, stability, and traceability in research environments.

GHS-R1a (Ghrelin Receptor) Agonist: Enables targeted studies of ghrelin-receptor pharmacology and downstream signaling
D-Amino Acid Composition: Enhances enzymatic resistance and conformational stability in experimental systems
Short-Chain Synthetic Hexapeptide: Suitable for structure–activity and receptor-kinetics studies
Purity ≥98%: Verified for analytical and experimental research
Lyophilized Powder Format: Supports long-term storage and controlled reconstitution
Sealed Vial Packaging: Ensures laboratory traceability and contamination control

GHRP-6 (10mg) Mechanism & Research Applications

GHRP-6 functions as a synthetic agonist of GHS-R1a, a G protein-coupled receptor (GPCR) expressed in the pituitary gland, hypothalamus, and distributed across the central nervous system and select peripheral tissues. Upon receptor binding, GHRP-6 activates Gq/PLC signaling, resulting in inositol triphosphate (IP₃) generation, intracellular calcium mobilization, and G protein–mediated kinase activation.

These signaling cascades regulate growth hormone secretion, modulate neuroendocrine circuits, influence metabolic sensing, and activate gene-expression programs associated with cellular stress response, inflammatory signaling, and apoptosis-related pathways. In research contexts, GHRP-6 is used to interrogate GHS-R1a activation kinetics, tissue-specific receptor expression, and downstream signal-transduction networks.

Primary Research Domains

Receptor Pharmacology: Ligand–response profiling, second-messenger assays, and structure–activity relationship analysis of GHS-R1a signaling
Neuroscience Research: Studies of learning and memory, synaptic plasticity, and dopaminergic system involvement
Ischemia & Cellular Stress Models: Evaluation of apoptosis markers, neuroinflammatory mediators, and cell-survival signaling
Tissue Remodeling & Extracellular Matrix Biology: Analysis of cell migration, collagen expression, and matrix-organization dynamics
Cardiac Cell Stress Paradigms: Investigation of oxidative cytotoxicity, necrosis markers, and myocardial injury responses
Motivation & Reward Circuitry: Behavioral studies examining reward-seeking outputs, site-dependent GHS-R activation, and neurobehavioral modulation

Preclinical Research Summary

Neural Plasticity & Memory Paradigms: Rodent studies have examined GHS-R signaling in extinction learning, amygdala-associated long-term depression, and memory encoding processes.
Ischemic Brain Injury Models: Preclinical models assess apoptosis-associated markers and neuroinflammatory signaling following GHRP-6-mediated receptor activation.
Dopaminergic System Mapping: Research has characterized GHS-R expression in the substantia nigra, linking receptor dynamics to motor-function phenotypes.
Extracellular Matrix Remodeling: Wound-healing models evaluate collagen deposition, proteome-level changes, and matrix organization during tissue repair.
Myocardial Injury & Oxidative Stress: Large-animal studies quantify oxidative injury indices, necrosis-related markers, and biochemical stress endpoints.
Motivation & Reward-Seeking Behavior: Behavioral paradigms investigate central GHS-R stimulation and its region-specific influence on motivated behavior.

GHRP-6 (10mg) Dosing & Observed Effects in Research

Published studies report microgram- to milligram-level dosing, adjusted according to experimental model, study duration, and research objective. Investigations span cell-based assays, tissue explants, rodent and murine models, and large-animal preclinical studies.

Commonly reported research endpoints include:

Growth hormone elevation
Learning- and memory-related behavioral changes
Alterations in apoptosis and necrosis signaling
Modulation of inflammatory mediators and cytokine expression
Changes in oxidative-stress and antioxidant pathways
Shifts in extracellular-matrix protein expression
Dopaminergic neuron response modulation
Reward-seeking and motivation-related behavioral outputs

All findings derive exclusively from preclinical research systems.

GHRP-6 (10mg) Storage, Safety & References

Store GHRP-6 (10mg) as a lyophilized powder protected from light and moisture.

Short-term storage: 2–8 °C (days to weeks)
Long-term storage: −20 °C or lower (−80 °C preferred)

After reconstitution, storage conditions depend on the diluent and study protocol. Avoid repeated freeze–thaw cycles. Standard laboratory safety procedures, aseptic handling, and proper labeling must be followed. Laboratories that order GHRP-6 peptide are responsible for regulatory compliance.